Similar Articles
2061 Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma
2062 Natural history of hepatitis-related hepatocellular carcinoma
2063 Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
2064 Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review
2065 Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
2066 Is human hepatocellular carcinoma a hormone-responsive tumor?
2067 Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma
2068 Activins and activin antagonists in hepatocellular carcinoma
2069 Current role of ultrasound for the management of hepatocellular carcinoma
2070 Tumor suppressor and hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA